Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Today, some studies estimate that 12% of Americans have used GLP-1 drugs for weight loss, potentially leading to a recent decline in obesity, while also offering benefits for comorbid conditions like sleep apnea and heart disease
STAT News Novo Nordisks $199 Ozempic Deal Shows What Telehealth Platforms Can Do for Pharma (statnews.com), November 18, 2025
Hims & Hers Health Inc
Option Cagrilintide Evidence for the added compound Human Phase 2 data alone and Phase 3 data with semaglutide Evidence for the retatrutide combination None identified Option Tesamorelin Evidence for the added compound Randomized trials and an FDA-approved narrow indication Evidence for the retatrutide combination None identified Option CJC-1295 + ipamorelin Evidence for the added compound Small human studies showing GH or IGF-1 response Evidence for the retatrutide combination None identified Option MOTS-C Evidence for the added compound Human observational biology plus mostly preclinical treatment research Evidence for the retatrutide combination None identified This ranking describes research depth
US$ 23.87
US$ 20.97
US$ 26.36
US$ 24.84
US$ 22.26
US$ 22.43
US$ 28.51
